Animal Cell Therapies, Inc. is a veterinary stem cell research and development company whose mission is to develop and standardize pure and potent high quality stem cell treatments for orthopedic and chronic diseases in dogs. Our novel approach aims to increase treatment efficacy, provide a consistent product, reduce pain, and be efficiently performed in an outpatient setting.
With 78 million dogs in the U.S. and a pet population growing twice as fast as the human population, the health and longevity of our pets is more important than ever. The problem is 1 in 4 dogs suffer from an orthopedic problem. Animal Cell Therapies, Inc. will deliver innovative cell-based therapies to improve the quality of life of our pets.
Animal Cell Therapies is currently conducting a Clinical Trial Evaluating the Effect of Intra-articular Allogeneic Umbilical-Derived Stem Cells for Dogs with Chronic Elbow Osteoarthritis in the following areas: University of Florida Gainesville, Florida. For additional information, please contact Kat at Kat.Rheinbold@actcells.com.